Strategic Investment Advisors MI Invests $1.31 Million in CME Group Inc. $CME

Strategic Investment Advisors MI bought a new position in shares of CME Group Inc. (NASDAQ:CME) in the 1st quarter, HoldingsChannel reports. The fund bought 4,425 shares of the financial services provider’s stock, valued at approximately $1,307,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in CME. Norges Bank purchased a new stake in shares of CME Group in the fourth quarter worth approximately $1,523,241,000. Victory Capital Management Inc. boosted its position in shares of CME Group by 746.4% during the fourth quarter. Victory Capital Management Inc. now owns 2,049,649 shares of the financial services provider’s stock valued at $559,720,000 after buying an additional 1,807,491 shares during the last quarter. Life Cycle Investment Partners Ltd bought a new stake in CME Group during the fourth quarter worth $217,656,000. Viking Global Investors LP bought a new stake in CME Group during the second quarter worth $164,648,000. Finally, Vanguard Group Inc. raised its position in CME Group by 1.7% in the 4th quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock valued at $9,802,366,000 after buying an additional 588,509 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Weiss Ratings cut CME Group from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 13th. Bank of America increased their target price on shares of CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a report on Thursday, July 23rd. Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and raised their price target for the company from $316.00 to $323.00 in a research report on Thursday, June 11th. Jefferies Financial Group cut their price target on shares of CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a report on Thursday, April 9th. Finally, Barclays reduced their price objective on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research report on Thursday, July 9th. Eleven research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, CME Group presently has an average rating of “Hold” and an average target price of $291.81.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Expanded retail access to futures: TradeStation is expanding its futures offering to include CME Group’s spot-quoted futures, potentially increasing participation, liquidity and transaction volume across CME’s markets. TradeStation Expands Futures Offering with CME Group Spot-Quoted Futures
• Positive Sentiment: Entry into sports-related derivatives: CME Group plans to launch cash-settled futures tied to sports performance indexes through a partnership with FutureSports. The initiative targets the roughly $650 billion global sports industry and could create a new source of trading and clearing revenue if it receives regulatory approval and attracts hedging demand. CME Group Targets $650 Billion Sports Industry With First Sports Index Futures
• Positive Sentiment: Recent earnings beat expectations: CME’s latest quarterly results exceeded consensus estimates, with earnings per share of $2.99 versus $2.91 expected and revenue of $1.71 billion versus $1.68 billion expected. Revenue increased year over year, reinforcing the company’s strong operating performance and high margins.
• Neutral Sentiment: Federal Reserve holds rates steady: The Fed kept its benchmark rate at 3.50%–3.75%, in line with expectations. The decision does not materially change CME’s outlook, though future rate uncertainty can support activity in interest-rate and other derivatives markets. Fed Holds Rates Between 3.50% and 3.75%
• Negative Sentiment: Minor earnings-estimate reduction: Erste Group Bank lowered its FY2027 EPS forecast to $12.91 from $12.94 and maintained a “Hold” rating. The small revision signals limited near-term upside from that analyst, though the estimate remains above the broader current-year consensus of $12.27.

CME Group Stock Up 0.7%

Shares of NASDAQ:CME opened at $267.36 on Friday. The company has a market capitalization of $96.88 billion, a PE ratio of 22.68, a price-to-earnings-growth ratio of 3.09 and a beta of 0.25. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The business has a fifty day moving average price of $251.35 and a two-hundred day moving average price of $281.15. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The company had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the prior year, the business earned $2.96 earnings per share. The firm’s revenue for the quarter was up .8% on a year-over-year basis. Analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were paid a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date was Tuesday, June 9th. CME Group’s payout ratio is presently 44.11%.

Insider Activity

In other news, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the sale, the chief executive officer owned 55,630 shares in the company, valued at $16,606,111.30. This trade represents a 38.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director William R. Shepard purchased 325 shares of the firm’s stock in a transaction dated Thursday, June 25th. The shares were bought at an average price of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director owned 260,442 shares in the company, valued at $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.